Brief: Captor Therapeutics Seeks EUR 7.8 Mln From EIC Accelerator For CT-03 AML Trials

Captor Therapeutics SA

17/02/2025 12:12

Feb 17 (Reuters) - Captor Therapeutics SA  CTXP.WA :
    * QUALIFIED FOR EIC ACCELERATOR PREPARATION FOR FUNDING AGREEMENT STAGE FOR
CT-03
PROJECT
    * PROJECT TO DEMONSTRATE SAFETY IN PHASE IA/IB TRIAL FOR AML PATIENTS
    * TOTAL REQUESTED FUNDING FOR PROJECT IS 7.8 MILLION EUROS

Source text:  ID:nEM1Y2K2Ca 
Further company coverage:  CTXP.WA 

 (Reporting by Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))